Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
11/15/2005 | US6965039 7-carboxy-flavone derivatives preparation method and therapeutic use |
11/15/2005 | US6965033 Bisamidate phosphonate prodrugs |
11/15/2005 | US6964746 Mixture of a phosphonite with other components |
11/15/2005 | CA2316878C Hydrogen-free regeneration of dithiophosphorus metal extractants |
11/15/2005 | CA2265724C Method for producing n-phosphonomethylglycine and its salts |
11/15/2005 | CA2204803C Process to prepare bridged phosphole-cyclopentadienyl compounds |
11/15/2005 | CA2200373C Heteroligand |
11/15/2005 | CA2179640C Watersoluble azole antifungals |
11/15/2005 | CA2172534C Conformationally locked nucleoside analogues |
11/15/2005 | CA2167183C Process for making hiv protease inhibitors |
11/15/2005 | CA2097383C Bisdithiophosphoric acid derivatives as lubricant additives |
11/15/2005 | CA2070120C Thioxanthenone antitumor agents |
11/10/2005 | WO2005105818A1 Process for the alkylation of phosphorus-containing compounds |
11/10/2005 | WO2005105780A2 Compositions useful as inhibitors of rock and other protein kinases |
11/10/2005 | WO2005105746A1 Organometallic complex, luminous solid, organic el element and organic el display |
11/10/2005 | WO2005060500A3 Process for manufacture of pentaerythritol diphosphites |
11/10/2005 | US20050250951 Chiral C2-symmetric biphenyls, their preparation and also metal complexes in which these ligands are present and their use as catalysts in chirogenic syntheses |
11/10/2005 | US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof |
11/10/2005 | US20050250742 Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1) |
11/10/2005 | US20050250189 Process for recovering serine |
11/10/2005 | US20050247913 Phosphorous ester compound, process for producing the same, and use thereof |
11/10/2005 | US20050247908 Curing agents for epoxy resins, use thereof and epoxy resin cured therewith |
11/10/2005 | CA2562883A1 Process for the alkylation of phosphorus-containing compounds |
11/09/2005 | EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity |
11/09/2005 | EP1592719A1 Conjugation reactions |
11/09/2005 | EP1592698A2 Phosphine compound, intermediate, palladium-complex, and use thereof |
11/09/2005 | EP1592696A1 Salts comprising cyanoborate anions |
11/09/2005 | EP1480990B1 Compounds for use as surfactants |
11/09/2005 | EP1438318B1 Tissue specific fluorescent chelates |
11/09/2005 | EP1252166B1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
11/09/2005 | EP1206427B1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
11/09/2005 | EP0988285B1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
11/09/2005 | EP0918775B1 Phenyl-substituted cyclic ketoenol |
11/09/2005 | CN1693308A Process for preparing dazoline phospho acid |
11/09/2005 | CN1226195C Activated carbon filter, ceramic filter element and water purification system mounted with the two filters |
11/09/2005 | CN1226099C Chiral iridium catalyst and its preparation method and its application in industrial synthesis of chiral alcohol |
11/08/2005 | US6963014 C13 alcohol mixture and functionalised C13 alcohol mixture |
11/08/2005 | US6963009 Use of a supplemental promoter in conjunction with a carbon-supported noble-metal-containing catalyst in liquid phase oxidation reactions |
11/08/2005 | US6963008 Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
11/08/2005 | US6963005 Complex containing a metal atom selected from Os, Ru, Rh, Pd, Ir, and pt, and a phosphorus containing bidentate ligand having a phenyl group and first atom(C(R2)2,N,O bonded to phenyl group, phosphorus is bonded to first atom and metal |
11/08/2005 | US6962907 such as 3-(aminocyclopentanyl)butylphosphinic acid ; GABA (gamma-amino-butyric acid) receptor agonists/antagonists; for memory enhancement |
11/08/2005 | US6962690 A tetraazamacrocyclic compounds, chelated with lanthanide, terbium, europium and dysprosium; visual contrast enhancement agents or diagnostic agents |
11/08/2005 | CA2319272C Novel aminoalkanesulphonic, -phosphonic and -phosphinic acid derivatives, their preparation and their use as medicaments |
11/08/2005 | CA2297294C Phosphonomethoxymethylpurine/pyrimidine derivatives |
11/08/2005 | CA2195677C Endothelin antagonists |
11/08/2005 | CA2149753C Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
11/03/2005 | WO2005104628A1 Organic electroluminescent element and manufacturing method thereof, organic compound containing phosphorus and manufacturing method thereof |
11/03/2005 | WO2005103247A1 Oligonucleotide probe |
11/03/2005 | WO2005102997A1 3,4-disubstituted maleimides for use as vascular damaging agents |
11/03/2005 | WO2005102176A1 Xanthene dyes |
11/03/2005 | WO2005084307A9 Use of lipid conjugates in the treatment of disease |
11/03/2005 | WO2005063777A8 Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation |
11/03/2005 | WO2005058916A3 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins |
11/03/2005 | WO2004096131A3 Inhibitors of akt activity |
11/03/2005 | US20050245768 Multimer forms of mono-and bis-acylphosphine oxides |
11/03/2005 | US20050245748 Using ruthenium complex as hydrogenation catalysts; for reduction of aldehydes, ketones, imines |
11/03/2005 | US20050245735 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
11/03/2005 | US20050245702 nickel, palladium, iron or cobalt complexes with neutral ligands that contain one or both of the imino (C=N) or phosphinidine (C=P) or (P-C=N) groups; polymerization of ethylene for example |
11/03/2005 | US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents |
11/03/2005 | US20050245488 Pharmaceutically active compounds and methods of use thereof |
11/03/2005 | US20050245487 Mitochondrially targeted antioxidants |
11/03/2005 | US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
11/02/2005 | EP1591447A1 Phospholipid derivatives and process for the production there |
11/02/2005 | EP1590356A2 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds |
11/02/2005 | EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
11/02/2005 | EP1311518B1 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts |
11/02/2005 | EP1294664B1 Alcohol mixtures having 13 and 15 carbon atoms and the use thereof in the preparation of surface-active substances |
11/02/2005 | EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
11/02/2005 | CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
11/02/2005 | CN1692108A Pesticidal heterocycles |
11/02/2005 | CN1690068A Pyrimidine derivatives and process for preparing same |
11/02/2005 | CN1690067A Antiviral agent cyclo-cidofovir derivatives |
11/02/2005 | CN1690066A Antiviral agent cidofovir derivatives |
11/02/2005 | CN1690065A Antiviral agent cidofovir derivatives and intermediates thereof |
11/02/2005 | CN1690064A Diphosphonic acid derivatives and preparation process and application thereof |
11/01/2005 | US6960675 a tantalum complex recursor for a barrier layer selected from tantalum nitride, tantalum oxide or bismuth tantalum oxide |
11/01/2005 | US6960572 Indolinones and uses thereof |
11/01/2005 | CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor |
10/27/2005 | WO2005100408A1 Process for photocuring with light emitting diodes |
10/27/2005 | WO2005100307A2 Methods of making an antistatic agent |
10/27/2005 | WO2005100300A1 5-aminolevulinic acid salt, process for producing the same and use thereof |
10/27/2005 | WO2004113275A3 Methods and compositions for treating amyloid-related diseases |
10/27/2005 | US20050240062 protecting 3,5-DIhydroxybenzaldehyde with diisopropylethylamine/N,N-/ and silyl chloride, reacting 3,5-di(tert-butyldimethylsilyloxy)-benzaldehyde product with 4-methoxybenzyltriphenylphosphonium bromide to obtain 3,5-di(tert-butyldimethylsilyloxy)-4'-methoxy-stilbene, deprotecting and separating |
10/27/2005 | US20050240015 Solution phase synthesis of oligonucleotides |
10/27/2005 | US20050239767 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands |
10/27/2005 | US20050239725 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
10/27/2005 | US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds |
10/27/2005 | DE10392233T5 Phosphor-enthaltende Organosiliciumverbindung, ein Verfahren zur Herstellung davon und eine Harzzusammensetzung oder eine Beschichtungszusammensetzung, welche diese enthalten Phosphorus-containing organosilicon compound, a process for preparation thereof and a resin composition or a coating composition containing these |
10/27/2005 | CA2562170A1 5-aminolevulinic acid salt, process for producing the same and use thereof |
10/26/2005 | EP1589028A2 Modified oligonucleotides, their preparation and their use |
10/26/2005 | EP1589025A2 Nucleic acid labeling compounds |
10/26/2005 | EP1589020A1 Novel compounds capable of forming photoconvertible organic thin films and articles having organic thin films |
10/26/2005 | EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
10/26/2005 | EP1587814A1 Industrial process for the synthesis of 2-substituted 1-(hydroxy-ethylidene)-1,1-bisphosphonic acids of high purity and the salts thereof |
10/26/2005 | EP1587813A1 Phosphonium and imidazolium salts and methods of their preparation |
10/26/2005 | EP1587518A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon |
10/26/2005 | EP1587513A2 Antineoplastic ether lipid compounds with modifications at the sn-2 carbon |
10/26/2005 | EP1450949B1 Process for the preparation of a nickel/phosphorus ligand catalyst for olefin hydrocyanation |
10/26/2005 | EP1450790A4 Photosensitizing carbamate derivatives |
10/26/2005 | EP1450774A4 Chlorin photosensitizing agents for use in photodynamic therapy |